|
    PRGO U.S.: NYSE

    Perrigo Co. PLC

    PRGOUS
    After Hours
    Last Updated: Sep 17, 2021 4:57 p.m. EDT Delayed quote

    $ 43.94

    0.00 0.00%
    After Hours Volume: 13.17M
    Close Chg Chg %
    $43.94 -0.34 -0.77%
    Advanced Charting
    Volume: 29.34M 65 Day Avg: 1.89M
    1,555% vs Avg
    43.64 Day Range 45.12
    38.20 52 Week Range 49.91

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    PRGO Overview

    Performance

    5 Day
    • 0.57%
    1 Month
    • 7.28%
    3 Month
    • -5.06%
    YTD
    • -1.74%
    1 Year
    • -6.65%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 6 Full Ratings

    Recent News

    Read full story

    Perrigo Co. PLC stock falls Friday, still outperforms market

    Read full story

    Perrigo Co. PLC stock falls Thursday, underperforms market

    Read full story

    Perrigo Co. PLC stock falls Wednesday, underperforms market

    Read full story

    Perrigo Co. PLC stock outperforms market on strong trading day

    Read full story

    Perrigo Co. PLC stock outperforms market on strong trading day

    Read full story

    Perrigo Co. PLC stock falls Friday, underperforms market

    Read full story

    Perrigo Co. PLC stock falls Thursday, underperforms market

    Read full story

    Perrigo Co. PLC stock outperforms competitors on strong trading day

    Read full story

    Perrigo to Buy Consumer Self-Care Company HRA Pharma in $2.1 Billion Deal. The Stock Is Rising.

    Perrigo to acquire consumer self-care company HRA Pharma for about $2.1 billion in cash

    Perrigo expects deal to close by end of first half of 2022

    Perrigo expects deal to add about EUR400 mln in net sales in full-year 2023

    Perrigo expects deal to add about $1 to adj. EPS in full-year 2023

    Perrigo to acquire consumer self-care company HRA Pharma for about $2.1 bln in cash

    Read full story

    Perrigo Co. PLC stock falls Tuesday, underperforms market

    Read full story

    Tinder Owner Match Will Join the S&P 500. The Stock Is Soaring.

    Match Group, Ceridian HCM and Brown & Brown to Join S&P 500

    Read full story

    Perrigo Co. PLC stock outperforms market on strong trading day

    Read full story

    Perrigo Co. PLC stock outperforms market on strong trading day

    Read full story

    Perrigo Co. PLC stock falls Wednesday, underperforms market

    Why Is Perrigo (PRGO) Up 7.1% Since Last Earnings Report?

    on Zacks.com

    Perrigo (PRGO) to Acquire Another Self-Care Company HRA Pharma

    on Zacks.com

    This Simple Thing Sent These 3 Nasdaq Stocks Soaring Tuesday

    on Motley Fool

    Is It Time to Buy the S&P 500's 3 Worst-Performing August Stocks?

    on Motley Fool

    Why Perrigo Stock Tumbled 16% This Week

    on Motley Fool

    Perrigo Q2 Results Miss Estimates; Affirms Sales Guidance

    on TipRanks.com

    Why Perrigo Stock Was Slipping Today

    on Motley Fool

    Perrigo Co PLC (PRGO) Q2 2021 Earnings Call Transcript

    on Motley Fool

    Perrigo (PRGO) Q2 Earnings Lag, Sales Hurt by Weak Cold Season

    on Zacks.com

    Perrigo (PRGO) Q2 Earnings and Revenues Lag Estimates

    on Zacks.com

    Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for

    on Zacks.com

    What's in Store for Perrigo (PRGO) This Earnings Season?

    on Zacks.com

    Stay Away From Low-Growth Organon

    on InvestorPlace.com

    Perrigo Completes Sale of Generic Rx Pharmaceuticals Business $1.55B

    on TipRanks.com

    Perrigo (PRGO) Up 2.9% Since Last Earnings Report: Can It Continue?

    on Zacks.com

    Perrigo Divests Mexico And Brazil OTC Units

    on TipRanks.com

    Analysts Offer Insights on Healthcare Companies: Perrigo Company (PRGO), Exagen (XGN) and Travere Therapeutics (TVTX)

    on SmarterAnalyst

    Perrigo Company PLC (PRGO) Q1 2021 Earnings Call Transcript

    on Motley Fool

    Perrigo (PRGO) Q1 Earnings Miss Estimates, Revenues In Line

    on Zacks.com

    Perrigo (PRGO) Q1 Earnings and Revenues Miss Estimates

    on Zacks.com

    Perrigo Co. PLC

    Perrigo Co. Plc engages in the provision of over-the-counter (OTC) self-care and wellness solutions. It operates through the following segments: Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment includes the OTC, infant formula, and oral self-care categories; divested animal health category; and contract manufacturing businesses in the U.S., Mexico, and Canada. The Consumer Self-Care International segment consists of the consumer self-care business primarily branded in Europe and Australia; store brand business in the United Kingdom and parts of Europe and Asia; and divested liquid licensed products business in the United Kingdom. The Prescription Pharmaceuticals segment commercializes and manufactures generic prescription products in the U.S. and diagnostic products in Israel. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

    Competitors

    Name Chg % Market Cap
    Johnson & Johnson -0.28% $433.7B
    Procter & Gamble Co. 0.16% $350.5B
    Abbott Laboratories -0.51% $224.78B
    Sanofi S.A. -0.15% €102.36B
    Reckitt Benckiser Group PLC -0.53% £41.87B
    Bayer AG -0.94% €44.42B
    Dr. Reddy's Laboratories Ltd. -0.86% ₹813.41B
    Aurobindo Pharma Ltd. -1.15% ₹436.99B
    Taisho Pharmaceutical Holdings Co. Ltd. 1.04% ¥541.96B
    Prestige Consumer Healthcare Inc. -0.68% $2.65B
    Competitor Data Provided ByCapital Cube Logo